The PPARα/γAgonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat

A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES

Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189 · see citing works

A RELATION BETWEEN NON-ESTERIFIED FATTY ACIDS IN PLASMA AND THE METABOLISM OF GLUCOSE

Dole, V. P. (1956) · Journal of Clinical Investigation · doi:10.1172/jci103259 · Cited by 3,470 · see citing works

Mechanisms for Insulin Resistance: Common Threads and Missing Links

Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294 · see citing works

Fuel selection in human skeletal muscle in insulin resistance: a reexamination.

Kelley, D. E., & Mandarino, L. J. (2000) · Diabetes · doi:10.2337/diabetes.49.5.677 · Cited by 1,017 · see citing works

Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction

Morino, K., Petersen, K. F., & Shulman, G. I. (2006) · Diabetes · doi:10.2337/db06-s002 · Cited by 853 · see citing works

Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.

Groop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812 · see citing works

Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue

Kosteli, A., Sugaru, E., Haemmerle, G., Martin, J. F., Lei, J., Zechner, R., & Ferrante, A. W. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42845 · Cited by 726 · see citing works

Estimation of glycogen in small amounts of tissue

Handel, E. V. (1965) · Analytical Biochemistry · doi:10.1016/0003-2697(65)90013-8 · Cited by 560 · see citing works

Metabolic flexibility and insulin resistance

Galgani, J. E., Moro, C., & Ravussin, E. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90558.2008 · Cited by 532 · cited 2× · see citing works

Dose-response curves for in vivo insulin sensitivity in individual tissues in rats

Kraegen, E. W., James, D. E., Jenkins, A. B., & Chisholm, D. J. (1985) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1985.248.3.e353 · Cited by 409 · see citing works

Improved Glycemic Control and Enhanced Insulin Sensitivity in Type 2 Diabetic Subjects Treated With Pioglitazone

Miyazaki, Y., Mahankali, A., Matsuda, M., Glass, L., Mahankali, S., Ferrannini, E., Cusi, K., Mandarino, L. J., & DeFronzo, R. A. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.710 · Cited by 407 · see citing works

Structure of the PPARα and -γ Ligand Binding Domain in Complex with AZ 242; Ligand Selectivity and Agonist Activation in the PPAR Family

Cronet, P., Petersen, J. F. W., Folmer, R. H. A., Blomberg, N., Sjöblom, K., Karlsson, U., Lindstedt, E., & Bamberg, K. (2001) · Structure · doi:10.1016/s0969-2126(01)00634-7 · Cited by 326 · see citing works

Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier

Divakaruni, A. S., Wiley, S. E., Rogers, G. W., Andreyev, A. Y., Petrosyan, S., Loviscach, M., Wall, E. A., Yadava, N., Heuck, A. P., Ferrick, D. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303360110 · Cited by 308 · see citing works

Skeletal muscle fat oxidation: Timing and flexibility are everything

Kelley, D. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25758 · Cited by 298 · see citing works

Mechanisms of the free fatty acid-induced increase in hepatic glucose production

Lam, T. K. T., Carpentier, A. C., Lewis, G. F., van de Werve, G., Fantus, I. G., & Giacca, A. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00033.2003 · Cited by 283 · see citing works

Diabetic Dyslipidemia

Chahil, T. J., & Ginsberg, H. N. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.06.002 · Cited by 233 · see citing works

Free fatty acids and skeletal muscle insulin resistance

Kraegen, E. W., & Cooney, G. J. (2008) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000319118.44995.9a · Cited by 206 · see citing works

Thiazolidinediones Increase Plasma-Adipose Tissue FFA Exchange Capacity and Enhance Insulin-Mediated Control of Systemic FFA Availability

Oakes, N. D., Thalén, P., Jacinto, S. M., & Ljung, B. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1158 · Cited by 168 · see citing works

Influence of Plasma Free Fatty Acids on Lipoprotein Synthesis and Diabetic Dyslipidemia

Julius, U. (2003) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2003-41284 · Cited by 131 · see citing works

The role of fibrate treatment in dyslipidemia: an overview

Katsiki, N., Nikolic, D., Montalto, G., Banach, M., Mikhailidis, D. P., & Rizzo, M. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319170020 · Cited by 131 · see citing works

Insulin Resistance and Metabolic Derangements in Obese Mice Are Ameliorated by a Novel Peroxisome Proliferator-activated Receptor γ-sparing Thiazolidinedione

Chen, Z., Vigueira, P. A., Chambers, K. T., Hall, A. M., Mitra, M. S., Qi, N., McDonald, W. G., Colca, J. R., Kletzien, R. F., & Finck, B. N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.363960 · Cited by 121 · see citing works

Tesaglitazar, a novel dual peroxisome proliferator-activated receptor α/γ agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population

Fagerberg, B., Edwards, S., Halmos, T., Łopatyński, J., Schuster, H., Stender, S., Birketvedt, G. S., Tonstad, S., Halldórsdóttir, S., & Gause‐Nilsson, I. A. M. (2005) · Diabetologia · doi:10.1007/s00125-005-1846-8 · Cited by 115 · see citing works

AZ 242, a novel PPARα/γ agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats

Ljung, B., Bamberg, K., Dahllöf, B., Kjellstedt, A., Oakes, N. D., Östling, J., Svensson, L., & Camejo, G. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200127-jlr200 · Cited by 110 · see citing works

Effect of tesaglitazar, a dual PPARα/γ agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12‐week dose-ranging trial

Goldstein, B. J., Rosenstock, J., Anzalone, D. A., Tou, C., & Öhman, K. P. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x154169 · Cited by 70 · see citing works

Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Agonists on Glycemic Control, Lipid Profile and Cardiovascular Risk

Derosa, G., & Maffioli, P. (2012) · Current Molecular Pharmacology · doi:10.2174/1874467211205020272 · Cited by 68 · see citing works

Peroxisome Proliferator-Activated Receptor (PPAR) Activation Induces Tissue-Specific Effects on Fatty Acid Uptake and Metabolism in Vivo—A Study Using the Novel PPARα/γ Agonist Tesaglitazar

Hegarty, B. D., Furler, S. M., Oakes, N. D., Kraegen, E. W., & Cooney, G. J. (2004) · Endocrinology · doi:10.1210/en.2004-0260 · Cited by 66 · see citing works

Relation of adipose tissue to metabolic flexibility

Sparks, L. M., Ukropcová, B., Smith, J. M., Pasarica, M., Hymel, D., Xie, H., Bray, G. A., Miles, J. M., & Smith, S. R. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.09.052 · Cited by 61 · see citing works

The effect of CP 68,722, a thiozolidinedione derivative, on insulin sensitivity in lean and obese Zucker rats

Bowen, L., Stein, P. P., Stevenson, R. W., & Shulman, G. I. (1991) · Metabolism · doi:10.1016/0026-0495(91)90124-f · Cited by 55 · see citing works

Development and initial evaluation of a novel method for assessing tissue-specific plasma free fatty acid utilization in vivo using (R)-2-bromopalmitate tracer

Oakes, N. D., Kjellstedt, A., Forsberg, G., Clementz, T., Camejo, G., Furler, S. M., Kraegen, E. W., Ölwegård-Halvarsson, M., Jenkins, A. B., & Ljung, B. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33520-3 · Cited by 54 · see citing works

2-deoxy-d-glucose metabolism in individual tissues of the rat in vivo

Jenkins, A. B., Furler, S. M., & Kraegen, E. W. (1986) · International Journal of Biochemistry · doi:10.1016/0020-711x(86)90036-4 · Cited by 52 · see citing works

Efficacy, safety and tolerability of tesaglitazar when added to the therapeutic regimen of poorly controlled insulin-treated patients with type 2 diabetes

Ratner, R. E., Parikh, S. J., & Tou, C. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.042 · Cited by 52 · see citing works

Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes

Oakes, N. D., Thalén, P., Aasum, E., Edgley, A. J., Larsen, T. S., Furler, S. M., Ljung, B., & Severson, D. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00233.2005 · Cited by 51 · see citing works

Effects of prolonged Acipimox treatment on glucose and lipid metabolism and on in vivo insulin sensitivity in patients with non-insulin dependent diabetes mellitus

Vaag, A. A., & Beck-Nielsen, H. (1992) · European Journal of Endocrinology · doi:10.1530/acta.0.1270344 · Cited by 45 · see citing works

Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, reduces atherosclerosis in female low density lipoprotein receptor deficient mice

Chira, E. C., McMillen, T. S., Wang, S., Haw, A., O’Brien, K. D., Wight, T. N., & Chait, A. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.12.012 · Cited by 37 · see citing works

Tesaglitazar, a dual PPARα/γ agonist, ameliorates glucose and lipid intolerance in obese Zucker rats

Oakes, N. D., Thalén, P., Hultstrand, T., Jacinto, S. M., Camejo, G., Wallin, B., & Ljung, B. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00252.2005 · Cited by 36 · see citing works

The dual PPARα/γ agonist tesaglitazar blocks progression of pre‐existing atherosclerosis in APOE*3Leiden.CETP transgenic mice

van der Hoorn, J., Jukema, J. W., Havekes, L. M., Lundholm, E., Camejo, G., Rensen, P. C. N., & Princen, H. M. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00109.x · Cited by 33 · see citing works

Tesaglitazar, a dual peroxisome proliferator-activated receptor α/γ agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance

Schuster, H., Fagerberg, B., Edwards, S., Halmos, T., Łopatyński, J., Stender, S., Birketvedt, G. S., Tonstad, S., Gause‐Nilsson, I. A. M., Halldórsdóttir, S., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.05.029 · Cited by 31 · see citing works

Identification and Synthesis of Novel Inhibitors of Acetyl-CoA Carboxylase with in Vitro and in Vivo Efficacy on Fat Oxidation

Keil, S., Müller, M., Zoller, G., Haschke, G., Schroeter, K., Glien, M., Ruf, S. G., Focken, I., Herling, A. W., & Schmoll, D. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101179e · Cited by 27 · see citing works

Roles of Fatty Acid Oversupply and Impaired Oxidation in Lipid Accumulation in Tissues of Obese Rats

Oakes, N. D., Kjellstedt, A., Thalén, P., Ljung, B., & Turner, N. A. (2013) · Journal of Lipids · doi:10.1155/2013/420754 · Cited by 20 · see citing works

Long-term effects of a sustained-release preparation of acipimox on dyslipidemia and glucose metabolism in non—insulin-dependent diabetes mellitus

Davoren, P. M., Kelly, W., Gries, F. A., Hübinger, A., Whately‐Smith, C., & Alberti, K. G. M. M. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90252-9 · Cited by 17 · see citing works

DUAL PPAR-ALPHA/GAMMA AGONIST TESAGLITAZAR BLOCKS PROGRESSION OF PRE-EXISTING ATHEROSCLEROSIS IN APOE*3LEIDEN.CETP TRANSGENIC MICE

van der Hoorn, J. W., Jukema, J. W., Havekes, L. M., et al. (2008) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(08)70837-7 · Cited by 15 · see citing works

Effect of insulin on [3H]deoxy-D-glucose pharmacokinetics in the rat

Furler, S. M., Jenkins, A. B., & Kraegen, E. W. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.255.6.e806 · Cited by 14 · see citing works

Improvement of postprandial lipid handling and glucose tolerance in a non-diabetic population by the dual PPARα/γ agonist, tesaglitazar

Fagerberg, B., Schuster, H., Birketvedt, G. S., et al. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.038 · Cited by 7 · see citing works

Correction of dysfunctional fatty acid metabolism using peroxisome proliferator activated receptor gamma agonists.

Oakes, N. D., Ljung, B., & Camejo, G. (2002) · Europe PMC (PubMed Central) · Cited by 5 · see citing works

Untitled work

Randle (1998) · doi:10.1002/(sici)1099-0895(199812)14:4

Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease

Smith, R. L., Soeters, M. R., Wüst, R. C. I., & Houtkooper, R. H. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00211 · Cited by 787 · see citing works

Contraction Activates Glycogen Synthase Independently of Initial Glycogen Concentration

Lai, Y., Kuo, C., & Jensen, J. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-200605001-00961

Substrate cycling between glucose 6-phosphate and glycogen occurs in Schistosoma mansoni

Tielens, A. G. M., VANDENHEUVEL, J., & VANDENBERGH, S. (1990) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(90)90013-c · Cited by 16 · see citing works

The Stimulation of Glycogen Synthesis and of Glycogen Synthetase in the Liver by the Administration of Glucose

WULF, H. D., & Hers, H. G. (1967) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1967.tb00104.x · Cited by 123 · see citing works

Glycogen depletion rather than glucose 6-Pincrements controls early glycogen recovery in human cultured muscle

Montell, E., Arias, A., & Gómèz‐Foix, A. M. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.276.5.r1489 · Cited by 16 · see citing works

An In Vivo Nuclear Magnetic Resonance Spectroscopic Study

David, M., Petit, W. A., Laughlin, M. R., Shulman, R. G., King, J., & Barrett, E. J. (1990) · Cited by 6 · see citing works